Gilead recently increased stakes in AlloVir, a developer of drugs to treat or prevent viral diseases, and Arcus Biosciences, a…
London (www.aktiencheck.de) - Rating-Update:
Carter Gould, Analyst von Barclays, stuft die Aktie von Gilead Sciences Inc. (ISIN: US3755581036, WKN 885823,…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Gilead Sciences (GILD) closed the most recent trading day at $76.56, moving -1.17% from the previous trading session....…
Gileads breast cancer drug Trodelvy gets positive CHMP opinion for a second indication in Europe....…
Gilead Sciences, Inc. (GILD) announces data on Hepcludex that reinforces the potential of bulevirtide as an effective and well-tolerated treatment…
FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) said that the Committee for Medicinal Products for Human Use (CHMP) of…
Gilead Gets Positive European Opinion for Additional Indication for Trodelvy...…
NORTHAMPTON, MA / ACCESSWIRE / June 21, 2023 / Gilead Sciences:As a young gay man growing up in Detroit, Joe…
Gilead Sciences (GILD) closed the most recent trading day at $77.71, moving -1.46% from the previous trading session....…
NORTHAMPTON, MA / ACCESSWIRE / June 14, 2023 / Gilead SciencesWhen Vicky Choi began her career as an engineer, she…
Gilead Sciences (GILD) closed the most recent trading day at $78.45, moving +0.76% from the previous trading session....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Das Instrument GIS US3755581036 GILEAD SCIENCES DL-,001 EQUITY wird cum Dividende/Zinsen gehandelt am 13.06.2023 und ex Dividende/Zinsen am…
Das Instrument GIS US3755581036 GILEAD SCIENCES DL-,001 EQUITY wird cum Dividende/Zinsen gehandelt am 13.06.2023 und ex Dividende/Zinsen am…
MOUNT GILEAD, N.C., June 12, 2023 /PRNewswire/ -- McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) reported consolidated net revenues…
Gilead Sciences (GILD) closed the most recent trading day at $76.08, moving -0.16% from the previous trading session....…
License from Gilead grants AbTherx worldwide rights to a novel human therapeutic antibody discovery platformMOUNTAIN VIEW and SAN DIEGO, CA…
Gilead (GILD) and Arcus announce data from the interim analysis of the mid-stage ARC-7 study on domvanalimab in the NSCLC…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Argus Research stufen die Aktie von Gilead Sciences Inc. (ISIN: US3755581036, WKN: 885823,…
MOUNT GILEAD, N.C., June 1, 2023 /PRNewswire/ -- McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) declared a dividend of…
NORTHAMPTON, MA / ACCESSWIRE / May 31, 2023 / After finishing medical school in the late 1990s, Bilal Piperdi wanted…
FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) said Friday that the Committee for Medicinal Products for Human Use or…
KEYNOTE CONVERSATIONS WITH DIANE VON FURSTENBERG; GES LINDA BOFF AND GENERAL MOTORS ALAN WEXLER TUBIS MARK ROTBLAT IN CONVERSATION WITH…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Arcus (RCUS) surges as it expands its previous research collaboration with partner Gilead, to focus on developing therapies for inflammatory…
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
BRÜSSEL (dpa-AFX) - Die Europäische Union hat sich weitere bis zu 2,25 Millionen Fläschchen des Corona-Medikaments…
BRÜSSEL (dpa-AFX) - Die Europäische Union hat sich weitere bis zu 2,25 Millionen Fläschchen des Corona-Medikaments…